US Patent 10774056 Substituted piperazines as selective HDAC1,2 inhibitors
Patent 10774056 was granted and assigned to Regenacy Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
107740560
Date of Patent
September 15, 2020
0Patent Application Number
165077270
Date Filed
July 10, 2019
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10774056 Substituted piperazines as selective HDAC1,2 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10774056
Date of patent
September 15, 2020
Patent application number
16507727
Date Filed
July 10, 2019
Patent primary examiner
Find more entities like US Patent 10774056 Substituted piperazines as selective HDAC1,2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
